Financial Performance - Sales for Q1 2025 were $2,290 million, a slight decrease of 0.9% from $2,310 million in Q1 2024[15] - Gross profit increased to $567 million in Q1 2025, up 6.6% from $532 million in Q1 2024[15] - Net earnings attributable to Eastman rose to $182 million in Q1 2025, compared to $165 million in Q1 2024, reflecting a growth of 10.3%[15] - Basic earnings per share attributable to Eastman increased to $1.58 in Q1 2025, up from $1.40 in Q1 2024, representing a 12.9% increase[15] - The company reported a consolidated EBT of $214 million for Q1 2025, up from $214 million in Q1 2024, indicating consistent earnings before tax[15] - Net earnings for Q1 2025 were $182 million, an increase from $165 million in Q1 2024, representing an increase of 10.3%[91] - Basic earnings per share (EPS) for Q1 2025 were $1.58, compared to $1.40 in Q1 2024, reflecting a growth of 12.9%[91] Assets and Liabilities - Total assets decreased to $14,971 million as of March 31, 2025, down from $15,213 million at the end of 2024[17] - Total liabilities decreased to $9,027 million as of March 31, 2025, down from $9,361 million at the end of 2024[17] - Cash and cash equivalents decreased significantly to $418 million from $837 million at the end of 2024[17] - Total current liabilities decreased from $2,708 million as of December 31, 2024, to $2,269 million as of March 31, 2025, a reduction of 16.3%[17] - Total borrowings amounted to $5,021 million as of March 31, 2025, slightly up from $5,017 million as of December 31, 2024[38] Cash Flow - Net cash used in operating activities was $167 million in Q1 2025, compared to a net cash used of $16 million in Q1 2024[20] - The company reported a net cash used in investing activities of $131 million in Q1 2025, compared to $179 million in Q1 2024[20] Inventory and Expenses - Total inventories increased to $2,116 million as of March 31, 2025, compared to $1,988 million as of December 31, 2024, reflecting a 6.4% increase[34] - Research and development expenses rose to $67 million in Q1 2025, up from $59 million in Q1 2024, indicating a focus on innovation[15] - Capital expenditures for Q1 2025 were $139 million, compared to $147 million in Q1 2024, showing a decrease of 5.4%[107] Environmental Matters - The company’s net environmental reserve for environmental contingencies totaled $282 million as of March 31, 2025, compared to $284 million at December 31, 2024[74] - Estimated future environmental expenditures for undiscounted remediation costs range from $250 million to $503 million as of March 31, 2025[75] - Environmental remediation liabilities decreased from $252 million at December 31, 2024, to $250 million at March 31, 2025[76] - The company does not anticipate that environmental matters will have a material adverse effect on its future financial position or cash flows[73] Shareholder Returns - Cash dividends declared for the first quarter of 2025 were $96 million, reflecting a dividend of $0.83 per share[83] - Cash dividends declared were $0.83 per share for Q1 2025, compared to $0.81 per share in Q1 2024, reflecting a 2.5% increase[92] Derivatives and Hedging - The company entered into fixed-to-fixed cross-currency swaps totaling $300 million in the first quarter of 2025 to hedge against foreign currency fluctuations[52] - The total net derivative assets decreased from $35 million on December 31, 2024, to a net liability of $15 million as of March 31, 2025[61] - The company recognized a net gain of $3 million from foreign exchange derivatives in Q1 2025, compared to a net loss of $5 million in Q1 2024[67] Stock Options and Compensation - Share-based compensation expense recognized in Q1 2025 was $23 million, up from $21 million in Q1 2024, marking a 9.5% increase[99] - Approximately 408 thousand stock options were granted in Q1 2025, compared to 389 thousand in Q1 2024, indicating an increase in stock option grants[100] - The fair value of stock options granted in Q1 2025 was $26.99, up from $21.16 in Q1 2024, reflecting a 27.0% increase[101]

1Q 2025 financial results Earnings referenced in this presentation and the accompanying prepared remarks exclude certain non-core items. "Adjusted EBIT" is Earnings Before Interest and Taxes ("EBIT") adjusted for non-core items. "Adjusted EBIT Margin" is Adjusted EBIT divided by GAAP sales. "Adjusted EBITDA" is Earnings Before Interest, Taxes, Depreciation, and Amortization adjusted for non-core items. "Net Debt" is total borrowings less cash and cash equivalents. "Net Debt to Adjusted EBITDA" is Net Debt d ...

Eastman Chemical Company (NYSE:EMN) Q1 2025 Earnings Conference Call April 25, 2025 8:00 AM ET Company Participants Greg Riddle - IR Mark Costa - Board Chair & CEO William McLain - EVP & CFO Conference Call Participants Patrick Cunningham - Citigroup David Begleiter - Deutsche Bank Aleksey Yefremov - KeyCorp Vincent Andrews - Morgan Stanley Jeff Zekauskas - JPMorgan Kevin McCarthy - Vertical Research Partners Frank Mitsch - Fermium Research Michael Sison - Wells Fargo James Cannon - UBS Operator Good day, e ...

Eastman Chemical Company (EMN) reported first-quarter 2025 earnings of $1.57 per share, reflecting a rise of 12.9% from the year-ago quarter's figure of $1.39.EMN posted adjusted earnings of $1.91 per share, up 18.6% from the year-ago quarter figure of $1.61. It surpassed the Zacks Consensus Estimate of $1.89.The company’s revenues in the first quarter were $2,290 million, which missed the Zacks Consensus Estimate of $2,308.6 million. Sales decreased around 1% from $2,310 million reported in the prior-year ...

Eastman Chemical (EMN) reported $2.29 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 0.9%. EPS of $1.91 for the same period compares to $1.61 a year ago.The reported revenue represents a surprise of -0.81% over the Zacks Consensus Estimate of $2.31 billion. With the consensus EPS estimate being $1.89, the EPS surprise was +1.06%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Stree ...

Eastman Chemical (EMN) came out with quarterly earnings of $1.91 per share, beating the Zacks Consensus Estimate of $1.89 per share. This compares to earnings of $1.61 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 1.06%. A quarter ago, it was expected that this specialty chemicals maker would post earnings of $1.58 per share when it actually produced earnings of $1.87, delivering a surprise of 18.35%.Over the last four quart ...

Exhibit 99.01 Eastman Announces First-Quarter 2025 Financial Results KINGSPORT, Tenn., April 24, 2025 – Eastman Chemical Company (NYSE:EMN) announced its first- quarter 2025 financial results. | (In | millions, | except | per | share | amounts; unaudited) 1Q2025 1Q2024 | | --- | --- | --- | --- | --- | --- | | Sales | revenue | | | | $2,290 $2,310 | | Earnings | before | | interest | and | taxes ("EBIT") 302 263 | | Adjusted | EBIT* | | | | 311 274 | | Earnings | per | diluted | | share | 1.57 1.39 | | Adju ...

Eastman Chemical Company’s (EMN) Eastman Turbo Oil 2330 (ETO 2330) has been added to the relevant Qualified Products List after receiving MIL-PRF-7808 Grade 3 specification approval from the U.S. Air Force. This confirmed that the product meets military-grade performance and safety standards for aircraft turbo oils.The new ETO 2330 has been designed for applications requiring reliable performance under demanding conditions, delivering superior lubrication and thermal stability. ETO 2330 also exhibits best-i ...

Eastman Chemical (EMN) shares rallied 12.1% in the last trading session to close at $81.48. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 23.1% loss over the past four weeks.EMN's rally follows a spike in material stocks after President Trump declared a 90-day pause of reciprocal tariffs for most nations.This specialty chemicals maker is expected to post quarterly earnings of $1.89 per share in its upcoming ...

Euro Manganese's Chvaletice Project Designated a Strategic Project under the EU's Critical Raw Materials Act April 01, 2025 9:52 AM EDT | Source: Euro Manganese Inc. Vancouver, British Columbia--(Newsfile Corp. - April 1, 2025) - Euro Manganese Inc. (TSXV: EMN) (ASX: EMN) (OTCQB: EUMNF) (FSE: E06) (the "Company") today announced that the Chvaletice Manganese Project (the "Chvaletice Project" or the "Project") has been designated a Strategic Project under the European Union's Critical Raw Materials Act ("CRM ...